Synovial Sarcoma SS18 Test

Introduction

The Synovial Sarcoma SS18 test is a specialized diagnostic procedure aimed at identifying genetic markers associated with Synovial Sarcoma, a rare and aggressive type of cancer that primarily affects the joints and soft tissues. This test is crucial for early detection and accurate diagnosis, which can significantly influence treatment decisions and outcomes.

What the Test Measures

This test employs the Fluorescence In Situ Hybridization (FISH) method to detect specific genetic abnormalities in tumor tissue samples. It focuses on identifying the SS18 gene fusion, which is a hallmark of Synovial Sarcoma.

Who Should Consider This Test?

Patients who exhibit symptoms such as persistent swelling, pain in the joints, or any unusual masses in soft tissues should consider this test. Additionally, individuals with a family history of cancer or those at higher risk due to previous cancer diagnoses may also benefit from this diagnostic tool.

Benefits of Taking the Test

• Early and accurate diagnosis of Synovial Sarcoma.
• Guides treatment options and management strategies.
• Provides peace of mind for patients and their families.
• Can help in monitoring the effectiveness of treatment.

Understanding Your Results

Results from the Synovial Sarcoma SS18 test are typically available within 7-8 days. A positive result indicates the presence of genetic markers associated with Synovial Sarcoma, while a negative result suggests that these markers are not present. It is important to discuss the results with a healthcare professional who can provide guidance on the next steps.

Pricing Information

Booking the Test

The Synovial Sarcoma SS18 test requires a doctor’s prescription, except for patients undergoing surgery, pregnancy cases, or those planning to travel abroad. We have branches across Kenya, making it convenient for you to access our services. Book the test today or call/whatsapp us at +254711564616!